Blog

WCAB Decisions in Almaraz/Guzman II

Date: September 3, 2009, Volume: 09-6, Issue: 03 On Thursday, September 3, 2009, the WCAB issued its en banc decisions in the long-awaited cases of Almaraz/Guzman ALMARAZ/GUZMAN II: The WCAB has handed down a 51 page 4 to 3 “split decision,” with the majority of Commissioners essentially validating what they did back in February, but […]

Read Blog Article

WCAB Decision in Ogilvie

Date:  September 3, 2009, Volume: 09-6, Issue: 04 On Thursday, September 3, 2009, the WCAB issued its en banc decision in Ogilvie: OGILVIE II: “DFEC is now alchemy.” Filed at the same time as its companion decision in Almaraz/Guzman, this en banc decision is in many ways parallel. A number of pages in these opinions […]

Read Blog Article

The New CMS Policies on Prescription Drug Set-Aside Guidelines

As everyone is now likely aware, CMS has set forth new policies effective June 1, 2009 for the methodology of pricing future prescription drug treatment costs and expenses contained within MSA proposals, submitted on and after that date. As is the case, CMS issues rules through its memoranda, reflecting policies and procedures. Fortunately, these are […]

Read Blog Article
Navigate Our Site